# Lineage Cell Therapeutics, Inc.: Form DEF 14A, filed Jul 27, 2023

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: DEF 14A
- Filed: 2023-07-27
- Accepted by EDGAR: Jul 27, 2023, 16:05 ET
- Period: 2023-07-27
- Accession: 0001493152-23-025680
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315223025680/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315223025680/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315223025680/formdef14a.htm

Filed Jul 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-025680. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
